The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
112293748 11229374 8 F 20160705 20150630 20160711 EXP PHHY2015BR077903 NOVARTIS 0.00 F Y 63.00000 KG 20160712 CN COUNTRY NOT SPECIFIED BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
112293748 11229374 1 PS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, QMO U 21008 30 MG SUSPENSION /month
112293748 11229374 2 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular UNK, AFTER 20 TO 25 DAYS U 21008 SUSPENSION
112293748 11229374 3 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular UNK, APPROXIMATELY EVERY 45 DAYS U 21008 SUSPENSION
112293748 11229374 4 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular UNK, EVERY 48 DAYS U 21008 SUSPENSION
112293748 11229374 5 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular UNK, ALMOST 2 MONTHS U 21008 SUSPENSION
112293748 11229374 6 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular UNK, EVERY 45 DAYS U 21008 SUSPENSION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
112293748 11229374 1 Neuroendocrine tumour

Outcome of event

Event ID CASEID OUTC COD
112293748 11229374 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
112293748 11229374 Needle issue
112293748 11229374 Ovarian cyst
112293748 11229374 Product use issue
112293748 11229374 Uterine neoplasm

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
112293748 11229374 1 2014 0
112293748 11229374 4 201601 0
112293748 11229374 5 201603 0
112293748 11229374 6 20160602 0